| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 03/13/1996 | EP0700444A1 Immunotoxins comprising gelonin and an antibody |
| 03/13/1996 | EP0700440A1 Regulator of contact-mediated hemolysin |
| 03/13/1996 | EP0700438A1 Opioid receptors: compositions and methods |
| 03/13/1996 | EP0700436A1 Tumour metastasis gene |
| 03/13/1996 | EP0700435A1 Transgenic mammals lacking expression of particular cd45 isoforms |
| 03/13/1996 | EP0700401A1 Human calcium sensor |
| 03/13/1996 | EP0487709B1 Dna probes and primers for detection of b. burgdorferi using the polymerase chain reaction |
| 03/07/1996 | WO1996006950A1 Reduction of nonspecific hybridization by using novel base-pairing schemes |
| 03/07/1996 | WO1996006944A1 Novel ribozymes and novel ribozyme selection systems |
| 03/07/1996 | WO1996006935A2 Arabinoxylan degrading enzymes |
| 03/07/1996 | WO1996006853A1 Activated nucleoside phosphoramidites and methods for the preparation and use thereof |
| 03/07/1996 | WO1996006850A1 Device for use in the isolation of a biological material such as nucleic acid |
| 03/07/1996 | WO1996006833A1 Novel nucleotide analogs |
| 03/07/1996 | WO1996006621A1 Metal complex containing oligonucleoside cleavage compounds and therapies |
| 03/07/1996 | CA2198863A1 Marker for individuals susceptible to alcoholism |
| 03/07/1996 | CA2198757A1 Device for use in the isolation of a biological material such as nucleic acid |
| 03/07/1996 | CA2197901A1 Reduction of nonspecific hybridization by using novel base-pairing schemes |
| 03/07/1996 | CA2197777A1 Novel ribozymes and novel ribozyme selection systems |
| 03/07/1996 | CA2174844A1 Arabinoxylan degrading enzymes |
| 03/07/1996 | CA2174216A1 Activated nucleoside phosphoramidites and methods for the preparation and use thereof |
| 03/06/1996 | EP0699764A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
| 03/06/1996 | EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |
| 03/06/1996 | EP0699753A2 Protein for the transport of cationic xenobiotic and/or pharmaceutical compounds, DNA sequences coding therefore and its uses |
| 03/06/1996 | EP0699240A1 Gibbon ape leukemia virus-based retroviral vectors |
| 03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 03/06/1996 | EP0699208A1 Novel peptide nucleic acids |
| 03/06/1996 | EP0699071A1 Anti-viral guanosine-rich oligonucleotides |
| 03/06/1996 | CN1118140A Oligonucleotides modified to improve stability at ACID pH |
| 03/06/1996 | CN1117972A Production technology for extracting nuclear acid from natural plant cells |
| 03/06/1996 | CA2157531A1 Htfiiia gene |
| 03/05/1996 | US5496938 Nucleic acid ligands to HIV-RT and HIV-1 rev |
| 03/05/1996 | US5496934 Nucleic acids encoding a cellulose binding domain |
| 03/05/1996 | US5496731 Anti-oncogenes |
| 03/05/1996 | US5496546 Compositions and methods of application of reactive antiviral polyadenylic acid derivatives |
| 03/05/1996 | US5496473 Apparatus for processing biopolymer-containing columns |
| 02/29/1996 | WO1996006190A2 Coupled amplification and ligation method |
| 02/29/1996 | WO1996006174A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES |
| 02/29/1996 | WO1996006107A1 Methods of identifying compounds useful for treating autoimmune diseases |
| 02/29/1996 | WO1996006105A1 Novel n-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith |
| 02/29/1996 | WO1996006104A1 Polynucleotide reagents having nonnucleotidic moieties, and associated methods of synthesis and use |
| 02/29/1996 | CA2196806A1 Polynucleotide reagents having nonnucleotidic moieties, and associated methods of synthesis and use |
| 02/29/1996 | CA2195562A1 Coupled amplification and ligation method |
| 02/29/1996 | CA2174534A1 Recombinant dnase b derived from streptococcus pyogenes |
| 02/28/1996 | EP0698667A1 Xylanase, microorganisms for its production, DNA molecules, process of preparation and use thereof |
| 02/28/1996 | EP0698095A1 Bmp-10 compositions |
| 02/28/1996 | EP0698094A1 Bmp-11 compositions |
| 02/28/1996 | EP0698093A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
| 02/28/1996 | EP0698092A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 02/28/1996 | EP0698034A1 Triester phosphorothioate oligonucleotides and method of preparation |
| 02/28/1996 | EP0697893A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 02/28/1996 | EP0697857A1 Hookworm anticoagulant |
| 02/28/1996 | EP0362367B1 Osteogenic devices |
| 02/27/1996 | US5495009 Oligonucleotide analogs containing thioformacetal linkages |
| 02/27/1996 | US5495006 Antiviral polynucleotide conjugates |
| 02/27/1996 | US5494816 Enhanced indole biosynthesis |
| 02/27/1996 | US5494807 NYVAC vaccinia virus recombinants comprising heterologous inserts |
| 02/27/1996 | US5494796 Using genus- and species-specific oligonucleotide probes |
| 02/27/1996 | US5494793 Covalently conjugated with physiological analyte; detectable markers fluorescent dyes or chromogens; elisa |
| 02/27/1996 | US5494654 Radiolabelled compound formulations |
| 02/26/1996 | CA2156231A1 Process for making the product of a nucleic acid amplification reaction incapable of being a target for further amplification, a diagnostic assay employing said process, a kit anda container |
| 02/22/1996 | WO1996005325A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | WO1996005321A1 Gene therapy for restenosis using an adenoviral vector |
| 02/22/1996 | WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 02/22/1996 | WO1996005298A1 Antitumor antisense oligonucleotides |
| 02/22/1996 | WO1996005297A1 Method of gene therapy using dna vectors without selection marker gene |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996005218A1 Delivery of nucleic acids |
| 02/22/1996 | WO1996005215A1 Solid support reagents for the synthesis of 3'-nitrogen containing polynucleotides |
| 02/22/1996 | WO1996005214A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | WO1996005213A1 Sequence-specific binding oligomers for nucleic acids and their use in antisense strategies |
| 02/22/1996 | WO1996004934A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004788A1 Antisense and triplex therapeutic agents and methods |
| 02/22/1996 | WO1995031470A3 Antisense inhibitors of gene expression |
| 02/22/1996 | DE4418691A1 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer 3 '- (4') non-radioactively labeled nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid-spacer |
| 02/22/1996 | CA2197420A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | CA2197117A1 Antisense and triplex therapeutic agents and methods |
| 02/22/1996 | CA2196306A1 Sequence-specific binding oligomers for nucleic acids and their use in antisense strategies |
| 02/22/1996 | CA2196208A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | CA2174232A1 Gene therapy for restenosis using an adenoviral vector |
| 02/21/1996 | EP0697461A1 Recombinant thermostable enzyme which releases trehalose from non-reducing saccharide |
| 02/21/1996 | EP0697414A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
| 02/20/1996 | US5493012 Forming permanent covalent crosslink; in vivo probes |
| 02/17/1996 | CA2156132A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 02/15/1996 | WO1996004403A1 Systematic evolution of ligands by exponential enrichment: chimeric selex |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996004295A1 5'-dithio-modified oligonucleotides |
| 02/15/1996 | WO1996004010A1 Vr-2332 viral nucleotide sequence and methods of use |
| 02/15/1996 | WO1995026982A3 Malaria peptides |
| 02/15/1996 | DE4428402A1 Gentherapeutisches Verfahren unter Verwendung von DNA-Vektoren ohne Selektionsmarker-Gen Gene therapy methods using DNA vectors without selectable marker gene |
| 02/15/1996 | CA2195864A1 5'-dithio-modified oligonucleotides |
| 02/14/1996 | EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus |
| 02/14/1996 | EP0696200A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 02/14/1996 | CN1116859A Detection of synthetic oligonucleotides extracted from body fluids or tissues |
| 02/13/1996 | US5491133 Contacting eukaryotic cell in vitro with oligodeoxynucleotide which has complementarity for and is hybridizable to specifed messenger rna region and has modified phosphodiester linkage resistant to exonuclease degradation |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/08/1996 | WO1996003510A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | WO1996003424A1 Combinatorial libraries of molecules and methods for producing same |
| 02/08/1996 | WO1996003418A1 Soluble combinatorial libraries |
| 02/08/1996 | WO1996003417A1 Improved methods of detritylation for oligonucleotide synthesis |